In the mouse model of non-alcoholic fatty liver disease (NAFLD), inhibiting the activity of ALKBH5 significantly induced hepatocytes autophagy by reducing the stability of AXL mRNA (Meng et al., 2023). Here, AXL is linked to metabolic dysfunction-associated steatotic liver disease.